Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners
- PMID: 17760979
- PMCID: PMC2040347
- DOI: 10.1186/1471-2334-7-100
Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners
Abstract
Background: The coinfections HIV/HCV/HBV are an important health issue in penitentiary communities. The aim of the study was to examine HIV, HBV and HCV coinfections determinants amongst prisoners in the jails of Southern Lazio (Central Italy), in the period 1995-2000.
Methods: Diagnosis of seropositivities for HIV, HBV and HCV was made using ELISA method. A multiple logistic regression analysis was conducted to verify the influence of socio-demographic factors on the HIV/HBV/HCV coinfections.
Results: HIV/HCV, HBV/HCV and HIV/HBV coinfections were detected in 42 (4%), 203 (17.9%) and 31 (2.9%) inmates, respectively. These coinfections are significantly associated with the status of drug addiction (OR = 16.02; p = 0.012; OR = 4.15; p < 0.001; OR = 23.57; p = 0.002), smoking habits (OR = 3.73; p = 0.033; OR = 1.42; p = 0.088; OR = 4.25; p = 0.053) and Italian nationality (OR = 7.05; p = 0.009; OR = 2.31; p < 0.001; OR = 4.61; p = 0.04).
Conclusion: The prevalence of HIV, HBV and HCV seropositivity in jails suggests that information and education programs for inmates could be useful to reduce the spread of such infections.
Similar articles
-
Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.J Infect Dev Ctries. 2013 Jun 15;7(6):453-67. doi: 10.3855/jidc.2965. J Infect Dev Ctries. 2013. PMID: 23771289
-
Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.J Med Virol. 2005 Jul;76(3):311-7. doi: 10.1002/jmv.20375. J Med Virol. 2005. PMID: 15902712
-
Prevalence of Hepatitis B virus and/or Hepatitis C virus co-infections in prisoners infected with the Human Immunodeficiency Virus.Int J Prison Health. 2008;4(2):77-82. doi: 10.1080/17449200802038207. Int J Prison Health. 2008. PMID: 18464061
-
Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysis.Arch Virol. 2020 Sep;165(9):1947-1958. doi: 10.1007/s00705-020-04716-1. Epub 2020 Jul 2. Arch Virol. 2020. PMID: 32617764
-
Prevalence of HIV, HCV and HBV in Central Asia and the Caucasus: A systematic review.Int J Infect Dis. 2021 Mar;104:510-525. doi: 10.1016/j.ijid.2020.12.068. Epub 2020 Dec 29. Int J Infect Dis. 2021. PMID: 33385583 Free PMC article.
Cited by
-
The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agenda.Elife. 2023 Feb 9;12:e81070. doi: 10.7554/eLife.81070. Elife. 2023. PMID: 36757862 Free PMC article.
-
Hepatitis C Prevalence Among Iranian Female prisoners.Hepat Mon. 2012 Sep;12(9):e8130. doi: 10.5812/hepatmon.8130. Epub 2012 Sep 30. Hepat Mon. 2012. PMID: 23087766 Free PMC article. No abstract available.
-
Seroprevalence and Associated Factors of Hepatitis B and Hepatitis C Viral Infections Among Prisoners in Tigrai, Northern Ethiopia.Infect Drug Resist. 2023 Jun 13;16:3743-3750. doi: 10.2147/IDR.S410017. eCollection 2023. Infect Drug Resist. 2023. PMID: 37333685 Free PMC article.
-
Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals.Qual Life Res. 2013 Sep;22(7):1525-35. doi: 10.1007/s11136-012-0283-7. Epub 2012 Oct 17. Qual Life Res. 2013. PMID: 23070749
-
Social determinants and risk behaviors associated with prevalent Hepatitis C and HIV/HCV co-infection among male injection drug users in Nepal.Arch Public Health. 2017 Sep 4;75:39. doi: 10.1186/s13690-017-0206-8. eCollection 2017. Arch Public Health. 2017. PMID: 28878895 Free PMC article.
References
-
- Highleyman L. HIV and hepatitis C coinfection. BETA. 2003;15:32–44. - PubMed
-
- Santana Rodriguez OE, Male Gil ML, HernandezSantana JF, Liminana Canal JM, Martin Sanchez AM. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. Eur J Epidemiol. 1998;14:555–61. doi: 10.1023/A:1007410707801. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical